ISIS Pharmaceuticals Inc $39.50

up +0.66


16/9/2014 05:03 PM  |  NASDAQ : ISIS  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get ISIS Trend Analysis - it has outperformed the S&P 500 by 9%

Partner Headlines

  1. Making Money With Charles Payne: 08/29/14

    FoxBusiness
  2. Tensions & Airlines Boost ETFs (ITA, PPA, BA, LMT)

    Benzinga
  3. Companies With 'ISIS' Name Get Unwanted Attention

    FoxBusiness
  4. Isis Pharmaceuticals Finally Breaks Out

    Benzinga
  5. CNBC's Stock Pops & Drops From August 26

    Benzinga
  6. Winners & Losers From Tuesday, August 26

    Benzinga
  7. Fast Money Picks For August 26

    Benzinga
  8. US Stock Futures Up Ahead Of Economic Data

    Benzinga
  9. UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. ...

    Benzinga
  10. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients ...

    Benzinga
  11. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga
  12. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  13. Isis Pharmaceuticals Earns $1M From GSK For Advancing Hepatitis B Virus ...

    Benzinga
  14. Benzinga's Top #PreMarket Losers

    Benzinga
  15. Brent Steady As Iraqi Exports Look Unaffected

    Benzinga
  16. Brent Retreats As Supply Interruption Worries Fade

    Benzinga
  17. Brent Up To $115 As ISIS Moves Toward Baghdad

    Benzinga
  18. Brent Climbs As Iraqi Oil Supplies Are Threatened

    Benzinga
  19. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  20. Morning Market Movers

    Benzinga
  21. UPDATE: Isis Pharmaceuticals Earns $10M Milestone Payment from Biogen Idec

    Benzinga
  22. US Stock Futures Decline Ahead Of Economic Data

    Benzinga
  23. Isis Pharma Announces Final Phase 2 Data on ISIS-GCGR Rx Showing Significant ...

    Benzinga
  24. Morning Market Movers

    Benzinga
  25. US Stock Futures Down Ahead Of Wholesale Trade Data

    Benzinga
  26. US Stock Futures Slightly Lower Ahead Of McDonald's Sales Report

    Benzinga
  27. Mid-Day Market Update: Fossil Drops On Downbeat Outlook; SunOpta Shares ...

    Benzinga
  28. Mid-Morning Market Update: Markets Open Lower; Macy's Posts Rise In Profit

    Benzinga
  29. Morning Market Movers

    Benzinga
  30. Benzinga's Top #PreMarket Gainers

    Benzinga
  31. US Stock Futures Edge Lower Ahead Of Producer Price Index

    Benzinga
  32. UPDATE: Piper Jaffray Upgrades ISIS Pharmaceuticals Following Mixed 1Q ...

    Benzinga
  33. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  34. Mid-Day Market Update: Twitter Drops On Earnings; Pepco Shares Gain

    Benzinga
  35. Isis Pharmaceuticals Shares Dropping Futher After Company released Updated ...

    Benzinga
  36. UPDATE: Isis Pharma Offers Updated Results from ISIS-SMN Rx Clinical Studies

    Benzinga
  37. Isis Pharmaceuticals to Present ISIS-SMN Rx Data at 2014 AAN Annual Meeting

    Benzinga
  38. Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx

    Benzinga
  39. EARLIER: Isis Announces Antisense Targeting of HBV Produces Dose-Dependent ...

    Benzinga
  40. BioMed Realty Trust Leases Space To Life Science Firms

    IBD
  41. US Stock Futures Edge Higher; All Eyes On Fed

    Benzinga
  42. US Stock Futures Tumble Ahead Of Economic Data

    Benzinga
  43. Earnings Scheduled For February 28, 2014

    Benzinga
  44. Mid-Afternoon Market Update: Groupon Shares Continue to Show Weakness Following ...

    Benzinga
  45. Mid-Day Market Update: Acacia Research Shares Decline On Downbeat Results; ...

    Benzinga
  46. US Stock Futures Rise Ahead Of Existing-Home Sales Data

    Benzinga
  47. Isis Pharmaceuticals Earns $2M Milestone Payment from GSK for Advancement ...

    Benzinga
  48. UPDATE: Piper Jaffray Assumes Coverage on ISIS Pharmaceuticals as Company's ...

    Benzinga
  49. Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-GSK3 Rx, Earns $3M ...

    Benzinga
  50. Isis Pharmaceuticals Announces Plan Investigate Higher Dose of ISIS-SMN ...

    Benzinga
Trading Center